Literature DB >> 2356396

Comparison of self- and spouse reports of snoring and other symptoms associated with sleep apnea syndrome.

C L Wiggins1, W W Schmidt-Nowara, D B Coultas, J M Samet.   

Abstract

We compared self- and spouse reports of snoring and other symptoms of sleep apnea syndrome ascertained from married couples in a community-based survey. Agreement between the two types of report varied between 70-98%, but was modest (kappa = -0.01-0.52) when adjusted for chance. For men, spouse reports yielded higher prevalence rates for snoring and for four other symptoms. For women, estimates of symptom prevalence were consistently lower by spouse report than by self-report. In multivariate analyses, the effect on snoring of gender and obesity increased and of age decreased when spouse reports were compared to self-reports. Snoring, according to spouse reports, was a significant risk factor for ischemic heart disease, but snoring according to self-reports showed a smaller effect and was not statistically significant. Snoring was not associated with hypertension when defined by either self- or spouse report. These observations suggest that questionnaire data of snoring and other symptoms of sleep apnea syndrome may be misclassified in part, and that such misclassification can affect estimates of prevalence and effects.

Entities:  

Mesh:

Year:  1990        PMID: 2356396     DOI: 10.1093/sleep/13.3.245

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  19 in total

1.  Validation and modification of the Epworth Sleepiness Scale in Peruvian population.

Authors:  Edmundo Rosales-Mayor; Jorge Rey de Castro; Leandro Huayanay; Kenny Zagaceta
Journal:  Sleep Breath       Date:  2011-01-30       Impact factor: 2.816

2.  Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort.

Authors:  Peter Elwood; Melissa Hack; Janet Pickering; Janie Hughes; John Gallacher
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

3.  Snoring and atherosclerotic manifestations in a 70-year-old population.

Authors:  P Jennum; K Schultz-Larsen; N J Christensen
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

4.  Screening for obstructive sleep apnea in veterans with ischemic heart disease using a computer-based clinical decision-support system.

Authors:  Rachel Laporta; Anil Anandam; Ali A El-Solh
Journal:  Clin Res Cardiol       Date:  2012-04-03       Impact factor: 5.460

5.  Calculating annoyance: an option to proof efficacy in ENT treatment of snoring?

Authors:  René Fischer; Thomas S Kuehnel; Anne-Kathrin Merz; Tobias Ettl; Michael Herzog; Christian Rohrmeier
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-22       Impact factor: 2.503

6.  Associations between sleep-disordered breathing, nocturnal hypoxemia, and subsequent cognitive decline in older community-dwelling men: the Osteoporotic Fractures in Men Sleep Study.

Authors:  Terri Blackwell; Kristine Yaffe; Alison Laffan; Susan Redline; Sonia Ancoli-Israel; Kristine E Ensrud; Yeonsu Song; Katie L Stone
Journal:  J Am Geriatr Soc       Date:  2015-03-02       Impact factor: 5.562

7.  Snoring, sympathetic activity and cardiovascular risk factors in a 70 year old population.

Authors:  P Jennum; K Schultz-Larsen; N Christensen
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

8.  The influence of nocturnal alcohol ingestion on snoring.

Authors:  Randolf Riemann; Ralf Volk; Alexander Müller; Michael Herzog
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-01       Impact factor: 2.503

9.  Clinical and polysomnographic differences between OSAH patients with/without excessive daytime sleepiness.

Authors:  Jorge Rey de Castro; Edmundo Rosales-Mayor
Journal:  Sleep Breath       Date:  2013-01-23       Impact factor: 2.816

10.  Are subjective assessments of snoring sounds reliable?

Authors:  Christian Rohrmeier; René Fischer; Anne-Kathrin Merz; Tobias Ettl; Michael Herzog; Thomas S Kuehnel
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.